Resolving erroneous reports in toxicology and therapeutic drug monitoring a comprehensive guide /

সংরক্ষণ করুন:
গ্রন্থ-পঞ্জীর বিবরন
প্রধান লেখক: Dasgupta, Amitava, 1958-
সংস্থা লেখক: ebrary, Inc
বিন্যাস: বৈদ্যুতিক বৈদ্যুতিন গ্রন্থ
ভাষা:ইংরেজি
প্রকাশিত: Hoboken, N.J. : John Wiley & Sons, c2012.
বিষয়গুলি:
অনলাইন ব্যবহার করুন:An electronic book accessible through the World Wide Web; click to view
ট্যাগগুলো: ট্যাগ যুক্ত করুন
কোনো ট্যাগ নেই, প্রথমজন হিসাবে ট্যাগ করুন!
সূচিপত্রের সারণি:
  • An introduction to tests performed in toxicology laboratories and methodologies available for such testings
  • Challenges in drugs of abuse testing
  • False positive results in immunoassays for drugs of abuse testing
  • True positive drugs of abuse test results due to prescription and non-prescription drugs
  • When toxicology report is negative in a suspected overdosed patient : the world of designer drugs
  • Abuse of magic mushroom, peyote cactus and solvent : no readily available laboratory tests
  • False positive alcohol tests using breath analyzers and automated analyzers
  • Role of laboratory in detecting other poisoning including pesticides, ethylene glycol, and methanol
  • Poisoning with warfarin and superwarfarin : what laboratory can do?
  • Plant poisoning and clinical laboratory
  • Sources of erroneous results in therapeutic drug monitoring due to pre-analytical errors, high bilirubin, hemolysis, and heterophilic antibody
  • Interferences in immunoassays used for digoxin monitoring
  • Interferences in immunoassays used for monitoring anticonvulsants and usefulness of monitoring free anticonvulsants in certain patients
  • Interferences in immunoassays used for monitoring tricyclic antidepressant
  • Therapeutic drug monitoring of immunosuppressant drugs : limitations of immunoassays and need for chromatographic methods
  • Effect of drug-herb interactions on therapeutic drug monitoring
  • Pharmacogenomics and toxicology laboratory
  • Approaches for eliminating interference/discordant specimen in therapeutic drug monitoring and drugs of abuse testing.